Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18679151 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia
Condition: Candidiasis
Interventions: Drug: Micafungin;   Drug: Liposomal Amphotericin B

Indicates status has not been verified in more than two years